$0.2948
At close: Apr 17 EDT
$0.3080
0.014.48%
Pre-Market: 6:19 AM EDT
Comments
Loading...
Stem Analyst Ratings and Price Targets | NYSE:STEM | Benzinga
Stem Inc has a consensus price target of $7.15 based on the ratings of 19 analysts. The high is $24 issued by Northland Capital Markets on September 7, 2022. The low is $0.3 issued by Piper Sandler on November 22, 2024. The 3 most-recent analyst ratings were released by UBS, Roth MKM, and BMO Capital on March 7, 2025, March 5, 2025, and March 5, 2025, respectively. With an average price target of $0.48 between UBS, Roth MKM, and BMO Capital, there's an implied 56.93% upside for Stem Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Roth MKM
BMO Capital
Piper Sandler
Goldman Sachs
Barclays
1calculated from analyst ratings
Analyst Ratings for Stem
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/14/2025 | Buy Now | — | UBS | Jon Windham59% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/07/2025 | Buy Now | 111.04% | UBS | Jon Windham59% | $0.6 → $0.65 | Maintains | Buy | Get Alert |
| 03/05/2025 | Buy Now | 29.87% | Roth MKM | Justin Clare44% | $0.35 → $0.4 | Maintains | Neutral | Get Alert |
| 03/05/2025 | Buy Now | 29.87% | BMO Capital | Ameet Thakkar43% | $0.5 → $0.4 | Maintains | Market Perform | Get Alert |
| 11/22/2024 | Buy Now | -2.6% | Piper Sandler | Kashy Harrison40% | $1.5 → $0.3 | Maintains | Neutral | Get Alert |
| 11/08/2024 | Buy Now | 94.81% | UBS | Jon Windham59% | $1 → $0.6 | Maintains | Buy | Get Alert |
| 11/01/2024 | Buy Now | 111.04% | Goldman Sachs | Brian Lee48% | $0.75 → $0.65 | Maintains | Neutral | Get Alert |
| 10/18/2024 | Buy Now | 224.68% | Barclays | Christine Cho50% | $4 → $1 | Maintains | Equal-Weight | Get Alert |
| 10/16/2024 | Buy Now | 94.81% | Susquehanna | Biju Perincheril42% | $0.5 → $0.6 | Maintains | Neutral | Get Alert |
| 08/09/2024 | Buy Now | 62.34% | Susquehanna | Biju Perincheril42% | $2 → $0.5 | Downgrade | Positive → Neutral | Get Alert |
| 08/08/2024 | Buy Now | 143.51% | Goldman Sachs | Brian Lee48% | $1.4 → $0.75 | Maintains | Neutral | Get Alert |
| 08/08/2024 | Buy Now | 224.68% | UBS | Jon Windham59% | $2.5 → $1 | Maintains | Buy | Get Alert |
| 08/07/2024 | Buy Now | 224.68% | TD Cowen | Thomas Boyes27% | $4 → $1 | Downgrade | Buy → Hold | Get Alert |
| 08/07/2024 | Buy Now | 1523.38% | Evercore ISI Group | James West63% | $9 → $5 | Maintains | Outperform | Get Alert |
| 07/15/2024 | Buy Now | 549.35% | Susquehanna | Biju Perincheril42% | $2.5 → $2 | Maintains | Positive | Get Alert |
| 05/08/2024 | Buy Now | 711.69% | UBS | Jon Windham59% | $5 → $2.5 | Maintains | Buy | Get Alert |
| 05/06/2024 | Buy Now | 549.35% | Goldman Sachs | Brian Lee48% | $2.5 → $2 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | 2822.08% | Evercore ISI Group | James West63% | $13 → $9 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | 500.65% | BMO Capital | Ameet Thakkar43% | $2.5 → $1.85 | Maintains | Market Perform | Get Alert |
| 04/11/2024 | Buy Now | 549.35% | Piper Sandler | Kashy Harrison40% | $3 → $2 | Maintains | Neutral | Get Alert |
| 03/22/2024 | Buy Now | 711.69% | Goldman Sachs | Brian Lee48% | $5.5 → $2.5 | Downgrade | Buy → Neutral | Get Alert |
| 02/29/2024 | Buy Now | 1198.7% | Susquehanna | Biju Perincheril42% | $5.5 → $4 | Maintains | Positive | Get Alert |
| 02/29/2024 | Buy Now | 874.03% | Piper Sandler | Kashy Harrison40% | $4 → $3 | Maintains | Neutral | Get Alert |
| 02/29/2024 | Buy Now | 955.19% | BMO Capital | Ameet Thakkar43% | $4 → $3.25 | Maintains | Market Perform | Get Alert |
| 01/24/2024 | Buy Now | 1848.05% | Goldman Sachs | Brian Lee48% | $7 → $6 | Maintains | Buy | Get Alert |
| 12/08/2023 | Buy Now | 1198.7% | Morgan Stanley | Stephen Byrd59% | $7 → $4 | Maintains | Equal-Weight | Get Alert |
| 11/03/2023 | Buy Now | — | Guggenheim | Joseph Osha76% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/02/2023 | Buy Now | 1101.3% | Roth MKM | Justin Clare44% | $6 → $3.7 | Maintains | Neutral | Get Alert |
| 11/01/2023 | Buy Now | 1101.3% | Roth MKM | Justin Clare44% | $6 → $3.7 | Maintains | Neutral | Get Alert |
| 10/24/2023 | Buy Now | 1523.38% | Barclays | Christine Cho50% | $6 → $5 | Maintains | Equal-Weight | Get Alert |
| 10/20/2023 | Buy Now | 1523.38% | Exane BNP Paribas | Moses Sutton71% | → $5 | Initiates | → Neutral | Get Alert |
| 10/17/2023 | Buy Now | 2172.73% | Morgan Stanley | Stephen Byrd59% | $8 → $7 | Maintains | Equal-Weight | Get Alert |
| 10/06/2023 | Buy Now | 1198.7% | Piper Sandler | Kashy Harrison40% | $5 → $4 | Maintains | Neutral | Get Alert |
| 09/08/2023 | Buy Now | 5419.48% | Evercore ISI Group | James West63% | $11 → $17 | Maintains | Outperform | Get Alert |
| 09/06/2023 | Buy Now | 2497.4% | Morgan Stanley | Stephen Byrd59% | $12 → $8 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/30/2023 | Buy Now | 1848.05% | Barclays | Christine Cho50% | → $6 | Initiates | → Equal-Weight | Get Alert |
| 07/20/2023 | Buy Now | 1848.05% | B of A Securities | Julien Dumoulin-Smith67% | $5 → $6 | Maintains | Underperform | Get Alert |
| 06/23/2023 | Buy Now | 1848.05% | Piper Sandler | Kashy Harrison40% | → $6 | Initiates | → Neutral | Get Alert |
| 06/14/2023 | Buy Now | 3796.1% | Morgan Stanley | Stephen Byrd59% | → $12 | Reiterates | → Overweight | Get Alert |
| 06/06/2023 | Buy Now | 3796.1% | Janney Montgomery Scott | Sean Milligan38% | → $12 | Initiates | → Buy | Get Alert |
| 05/24/2023 | Buy Now | 3471.43% | Evercore ISI Group | James West63% | → $11 | Initiates | → Outperform | Get Alert |
| 04/06/2023 | Buy Now | 2984.42% | UBS | Jon Windham59% | $18 → $9.5 | Maintains | Buy | Get Alert |
| 04/06/2023 | Buy Now | — | Wolfe Research | Steve Fleishman56% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 04/04/2023 | Buy Now | 1523.38% | B of A Securities | Julien Dumoulin-Smith67% | $9 → $5 | Downgrade | Neutral → Underperform | Get Alert |
| 04/03/2023 | Buy Now | 3796.1% | Morgan Stanley | Stephen Byrd59% | $15 → $12 | Maintains | Overweight | Get Alert |
| 03/30/2023 | Buy Now | 3796.1% | Susquehanna | Biju Perincheril42% | $17 → $12 | Maintains | Positive | Get Alert |
| 03/30/2023 | Buy Now | 3796.1% | Goldman Sachs | Brian Lee48% | $14 → $12 | Maintains | Buy | Get Alert |
| 02/21/2023 | Buy Now | 4445.45% | Goldman Sachs | Brian Kleinhanzl65% | $16 → $14 | Maintains | Buy | Get Alert |
| 02/21/2023 | Buy Now | 6393.51% | Credit Suisse | Maheep Mandloi38% | $24 → $20 | Maintains | Outperform | Get Alert |
| 02/17/2023 | Buy Now | 5419.48% | Susquehanna | Biju Perincheril42% | $20 → $17 | Maintains | Positive | Get Alert |
| 02/10/2023 | Buy Now | 3471.43% | B of A Securities | Julien Dumoulin-Smith67% | → $11 | Initiates | → Neutral | Get Alert |
| 01/10/2023 | Buy Now | 4770.13% | Morgan Stanley | Stephen Byrd59% | → $15 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/20/2022 | Buy Now | 5094.81% | Goldman Sachs | Brian Lee48% | $18 → $16 | Maintains | Buy | Get Alert |
| 10/25/2022 | Buy Now | 6068.83% | UBS | Jon Windham59% | → $19 | Initiates | → Buy | Get Alert |
| 09/29/2022 | Buy Now | 6393.51% | Cowen & Co. | Thomas Boyes27% | $22 → $20 | Maintains | Outperform | Get Alert |
| 09/29/2022 | Buy Now | 6718.18% | Morgan Stanley | Stephen Byrd59% | $20 → $21 | Maintains | Equal-Weight | Get Alert |
| 09/22/2022 | Buy Now | 7042.86% | Cowen & Co. | Thomas Boyes27% | → $22 | Initiates | → Outperform | Get Alert |
| 09/07/2022 | Buy Now | 7692.21% | Northland Capital Markets | Abhishek Sinha15% | → $24 | Initiates | → Outperform | Get Alert |
| 08/18/2022 | Buy Now | 6393.51% | Morgan Stanley | Stephen Byrd59% | $13 → $20 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Stem (STEM) stock?
The latest price target for Stem (NYSE:STEM) was reported by UBS on April 14, 2025. The analyst firm set a price target for $0.00 expecting STEM to fall to within 12 months (a possible -100.00% downside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Stem (STEM)?
The latest analyst rating for Stem (NYSE:STEM) was provided by UBS, and Stem downgraded their neutral rating.
When was the last upgrade for Stem (STEM)?
The last upgrade for Stem Inc happened on January 10, 2023 when Morgan Stanley raised their price target to $15. Morgan Stanley previously had an equal-weight for Stem Inc.
When was the last downgrade for Stem (STEM)?
The last downgrade for Stem Inc happened on April 14, 2025 when UBS changed their price target from N/A to N/A for Stem Inc.
When is the next analyst rating going to be posted or updated for Stem (STEM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Stem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Stem was filed on April 14, 2025 so you should expect the next rating to be made available sometime around April 14, 2026.
Is the Analyst Rating Stem (STEM) correct?
While ratings are subjective and will change, the latest Stem (STEM) rating was a downgraded with a price target of $0.00 to $0.00. The current price Stem (STEM) is trading at is $0.31, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
